Pharmadrug Inc. (CSE:PHRX)
Canada
· Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
May 13, 2025, 3:29 PM EDT
Pharmadrug Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 0.08 | 0.41 | 0.01 | 0.96 | 2.13 | Upgrade
|
| Short-Term Investments | - | 0.01 | 0.32 | 0.34 | 2.27 | Upgrade
|
| Cash & Short-Term Investments | 0.08 | 0.42 | 0.33 | 1.3 | 4.4 | Upgrade
|
| Cash Growth | -82.26% | 28.49% | -74.58% | -70.59% | 757.33% | Upgrade
|
| Accounts Receivable | - | - | - | 0.02 | 0.04 | Upgrade
|
| Other Receivables | 0.02 | 0.02 | 0.02 | 0.06 | 0.15 | Upgrade
|
| Receivables | 0.02 | 0.02 | 1 | 0.08 | 0.18 | Upgrade
|
| Inventory | - | - | - | 0.16 | 0.04 | Upgrade
|
| Prepaid Expenses | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Restricted Cash | 0.04 | 0.15 | - | - | - | Upgrade
|
| Other Current Assets | - | - | - | 0.05 | 0.03 | Upgrade
|
| Total Current Assets | 0.15 | 0.6 | 1.34 | 1.59 | 4.69 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0.1 | 0.12 | Upgrade
|
| Goodwill | - | - | 6.24 | 10.47 | 4.59 | Upgrade
|
| Other Intangible Assets | 0.56 | 0.6 | 4.53 | 7.35 | 4.29 | Upgrade
|
| Total Assets | 0.71 | 1.2 | 12.11 | 19.52 | 13.69 | Upgrade
|
| Accounts Payable | 0.61 | 0.45 | 0.53 | 0.25 | 0.35 | Upgrade
|
| Accrued Expenses | - | 0.45 | 0.25 | 0.19 | 0.21 | Upgrade
|
| Current Portion of Long-Term Debt | 1.35 | 1.77 | 1.42 | - | - | Upgrade
|
| Current Portion of Leases | - | - | - | 0.04 | 0.06 | Upgrade
|
| Total Current Liabilities | 1.96 | 2.66 | 2.2 | 0.48 | 0.62 | Upgrade
|
| Long-Term Debt | - | - | - | 0.79 | 1.03 | Upgrade
|
| Long-Term Leases | - | - | - | 0.04 | 0.04 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 1.01 | 1.25 | 1 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.07 | 0.1 | 0.09 | Upgrade
|
| Total Liabilities | 1.96 | 2.66 | 3.28 | 2.66 | 2.78 | Upgrade
|
| Common Stock | 33.99 | 33.21 | 31.22 | 30.61 | 21.83 | Upgrade
|
| Retained Earnings | -39.11 | -38.3 | -25.12 | -19.4 | -15.86 | Upgrade
|
| Comprehensive Income & Other | 3.71 | 3.38 | 2.74 | 5.66 | 3.68 | Upgrade
|
| Total Common Equity | -1.4 | -1.7 | 8.84 | 16.87 | 9.66 | Upgrade
|
| Minority Interest | 0.16 | 0.24 | - | - | 1.26 | Upgrade
|
| Shareholders' Equity | -1.24 | -1.47 | 8.84 | 16.87 | 10.91 | Upgrade
|
| Total Liabilities & Equity | 0.71 | 1.2 | 12.11 | 19.52 | 13.69 | Upgrade
|
| Total Debt | 1.35 | 1.77 | 1.42 | 0.87 | 1.13 | Upgrade
|
| Net Cash (Debt) | -1.27 | -1.34 | -1.09 | 0.43 | 3.28 | Upgrade
|
| Net Cash Growth | - | - | - | -86.91% | - | Upgrade
|
| Net Cash Per Share | -0.01 | -0.02 | -0.02 | 0.01 | 0.16 | Upgrade
|
| Filing Date Shares Outstanding | 103.3 | 104.69 | 50.8 | 49.48 | 48.62 | Upgrade
|
| Total Common Shares Outstanding | 103.3 | 88.17 | 50.8 | 48.69 | 34.52 | Upgrade
|
| Working Capital | -1.81 | -2.07 | -0.86 | 1.11 | 4.07 | Upgrade
|
| Book Value Per Share | -0.01 | -0.02 | 0.17 | 0.35 | 0.28 | Upgrade
|
| Tangible Book Value | -1.97 | -2.31 | -1.94 | -0.96 | 0.78 | Upgrade
|
| Tangible Book Value Per Share | -0.02 | -0.03 | -0.04 | -0.02 | 0.02 | Upgrade
|
| Machinery | - | - | - | 0.05 | 0.05 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.